2024 UK Sexually-Transmitted Disease (STD) Molecular Diagnostics Market: Shares and Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis

2024 UK Sexually-Transmitted Disease (STD) Molecular Diagnostics Market: Shares and Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis

About This Report

This new report from LeadingMarketResearch.com presents detailed analysis of the U.K. STD market. Current scientific views on epidemiology and etiology are presented for:

AIDS/HIV
Chancroid
Chlamydia
Gonorrhea
Granuloma Inguinale
Herpes I/II
Lymphogranuloma
Mycoplasma
Papillomavirus
Syphilis
Trichomonas Vaginalis

The report provides test volume and sales projections for:

Hospitals
Commercial/Private Labs
Public Health Labs

In addition to market share and sales forecasts, the report:

Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

Reviews features and operating characteristics of major analyzers used for STD testing;

Profiles key suppliers and potential market entrants developing innovative technologies and products; and

Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.